Michael Sitzman, a life sciences litigator, explains how McDermott’s busy schedule at the UPC convinced him to join
In the latest UPC update, we examine a ruling on director liability, another on the Gillette defence, and look ahead to cases concerning medical devices
A&O Shearman’s co-heads of IP litigation say the addition of US partners post-merger ensures the firm is well poised to tap into the world’s major markets
Chad Landmon explains how he recruited a former life sciences litigation colleague to the firm and reveals one of the key clients that he brought over
In the latest UPC update, we review the NanoString and iMop rulings, a big move in London and a decision on whether a patent pool administrator can intervene
Benjamin Sodey, a former in-house lawyer at life sciences business MilliporeSigma, says he's looking forward to expanding his practice at Polsinelli
Vince Shier and Ryan Smith, who recently joined Brown Rudnick, say their new firm offers a strong platform to provide strategic advice
Hiroshi Sheraton will join the firm alongside a transactional specialist from Covington & Burling
A trio of life sciences experts who moved to Morrison Foerster from Desmarais praised their new firm’s ‘outstanding’ litigation work
Data from Managing IP+’s Talent Tracker shows that the IP ambitions of Asian full-service firms and a life sciences focus in the US have prompted lateral moves
Chad Landmon, who joins in Washington DC, hopes to expand the firm’s Hatch-Waxman practice
Alban Kang, who has joined Singapore-based Robinson after three decades at Bird & Bird ATMD, shares why he’s eyeing AI and patent cases
Sponsored
Sponsored
-
Sponsored by Wanhuida Intellectual PropertyJianhui Li and Honghui Hu of Wanhuida Intellectual Property discuss the antitrust scrutiny of China’s Supreme People’s Court in a patent infringement appeal concerning reverse payment settlement agreement
-
Sponsored by Purplevine IPXiaojuan Yu of Purplevine IP Group discusses the medical device industry in China and considers why changes to the law are welcomed
-
Sponsored by FB RiceLee Miles of FB Rice discusses Australia’s patent box scheme which is set to introduce the agricultural and low emissions technology sectors
-
Sponsored by Gün and PartnersBarış Kalaycı and Direnç Bada of Gün and Partners discuss an IP case that led to the discovery, and removal, of fake fire-resistant glass from hospitals in Turkey
-
Sponsored by Wanhuida Intellectual PropertyThe China Patent Office upheld the validity of the patent over the antihistamine desloratadine citrate disodium, as Yue Guan from Wanhuida Intellectual Property explains
-
Sponsored by Remfry & SagarShukadev Khuraijam and Ankush Verma of Remfry & Sagar discuss pre-grant straw man oppositions in India and the impact of a recent decision of the Bombay High Court
Attorneys reveal how they navigate uncertainty in the CRISPR space and what developments they're watching
Jeffrey Morton, who moved to Haynes Boone in May, says he's excited about what the firm can do in San Diego as it looks to bolster its life sciences offering
Irena Royzman, who joined Orrick earlier this year, explains how she's collaborated with her new colleagues to address IP policy concerns
We provide a rundown of Managing IP’s news and analysis from the week, and review what’s been happening elsewhere in IP
Interviews; Exclusives
Interviews; Exclusives
Paul Johns, IP litigation head for Pearce IP in New Zealand, discusses how the firm is becoming a truly trans-Tasman outfit by onboarding dual-qualified lawyers
Daphne Lainson discusses feeding cats at 4.30am and why Dolly Parton is an inspiration
Partners at Anderson Mori & Tomotsune say AI and the UPC are providing new business opportunities and reveal why flexibility is key to retaining talent
Procopio partner Jeremy Edwards explains how his team identified the best prior art when seeking to cancel a patent
Naomi Pearce of Pearce IP shares how she is helping her firm become a life sciences leader and how generous policies have helped attract top talent
Each week Managing IP speaks to a different IP practitioner about their life and career
-
Weekly take: Why the EU must press ahead with unitary SPCs
The EU should press ahead with plans to introduce a unitary SPC and the UPC and EUIPO should play leading roles, says Jörg Thomaier at Bayer -
Weekly take: IP-trade demands will fail future generations
The bedaquiline case highlights why tools such as India’s pre-grant opposition mechanism are so important -
Weekly take: No harm in senators exploring patent alternatives
A proposed study into delinkage may not amount to much, and must be backed by strong evidence, but it can’t hurt to look into the issue -
Opinion: Indian domestic policy must match WTO stand on IP waivers
India has been both urging for vaccine waivers before the WTO and refusing compulsory licensing in the country, but it’s not helping anyone